Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,380 | -7,559 | -45,522 | -32,539 | -24,790 |
| Depreciation Amortization | 154 | 129 | 857 | 680 | 499 |
| Accounts payable and accrued liabilities | -211 | 197 | 1,880 | 1,719 | 1,653 |
| Other Working Capital | -5,446 | -5,480 | 3,996 | 1,786 | -318 |
| Other Operating Activity | -1,285 | -274 | 7,280 | 3,324 | 2,779 |
| Operating Cash Flow | $-22,168 | $-12,987 | $-31,509 | $-25,030 | $-20,177 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 39,046 | 39,046 | 39,046 |
| PPE Investments | 20 | 20 | 1,170 | 1,170 | 1,170 |
| Investing Cash Flow | $20 | $20 | $40,216 | $40,216 | $40,216 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 23 | 14 | 14 |
| Financing Cash Flow | $N/A | $N/A | $23 | $14 | $14 |
| Beginning Cash Position | 46,303 | 46,303 | 37,573 | 37,573 | 37,573 |
| End Cash Position | 24,155 | 33,336 | 46,303 | 52,773 | 57,626 |
| Net Cash Flow | $-22,148 | $-12,967 | $8,730 | $15,200 | $20,053 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,168 | -12,987 | -31,509 | -25,030 | -20,177 |
| Free Cash Flow | -22,168 | -12,987 | -31,509 | -25,030 | -20,177 |